These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38388188)

  • 1. Personalised preinterventional risk stratification of mortality, length of stay and hospitalisation costs in transcatheter aortic valve implantation using a machine learning algorithm: a pilot trial.
    Zisiopoulou M; Berkowitsch A; Redlich L; Walther T; Fichtlscherer S; Leistner DM
    Open Heart; 2024 Feb; 11(1):. PubMed ID: 38388188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Method to Predict Mortality and Length of Stay after Transfemoral Transcatheter Aortic Valve Implantation.
    Zisiopoulou M; Berkowitsch A; Seppelt P; Zeiher AM; Vasa-Nicotera M
    Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946277
    [No Abstract]   [Full Text] [Related]  

  • 3. Machine learning-based predictive risk models for 30-day and 1-year mortality in severe aortic stenosis patients undergoing transcatheter aortic valve implantation.
    Lertsanguansinchai P; Chokesuwattanaskul R; Petchlorlian A; Suttirut P; Buddhari W;
    Int J Cardiol; 2023 Mar; 374():20-26. PubMed ID: 36529306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of heart-team-guided treatment decisions in high-risk patients with aortic valve stenosis in a health-economic context with limited resources for transcatheter valve therapies.
    Bakelants E; Belmans A; Verbrugghe P; Adriaenssens T; Jacobs S; Bennett J; Meuris B; Desmet W; Rega F; Herijgers P; Herregods MC; Dubois CL
    Acta Cardiol; 2019 Dec; 74(6):489-498. PubMed ID: 30507297
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
    Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation?
    Watanabe Y; Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
    Catheter Cardiovasc Interv; 2013 May; 81(6):1053-60. PubMed ID: 23074135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of one- and two-year mortality after transcatheter aortic valve implantation: proposal of a fast sum-score system integrating a novel biomarker of cardiac extracellular matrix accumulation and fibrosis.
    Bäz L; Grün K; Diab M; Pfeil A; Jung C; Möbius-Winkler S; Schulze PC; Franz M
    Rev Cardiovasc Med; 2022 Feb; 23(2):62. PubMed ID: 35229553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.
    Zahn R; Werner N; Gerckens U; Linke A; Sievert H; Kahlert P; Hambrecht R; Sack S; Abdel-Wahab M; Hoffmann E; Zeymer U; Schneider S;
    Heart; 2017 Dec; 103(24):1970-1976. PubMed ID: 28684438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the choice between transcatheter and surgical treatment of severe aortic stenosis in patients younger than 80 years: Results from the OBSERVANT study.
    Tarantini G; Nai Fovino L; D'Errigo P; Rosato S; Barbanti M; Tamburino C; Ranucci M; Santoro G; Badoni G; Seccareccia F;
    Catheter Cardiovasc Interv; 2020 May; 95(6):E186-E195. PubMed ID: 31423704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of existing prediction models of 30-day mortality after Transcatheter Aortic Valve Implantation (TAVI) in the Netherlands Heart Registration.
    Al-Farra H; Abu-Hanna A; de Mol BAJM; Ter Burg WJ; Houterman S; Henriques JPS; Ravelli ACJ;
    Int J Cardiol; 2020 Oct; 317():25-32. PubMed ID: 32450275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel geriatric assessment frailty score predicts 2-year mortality after transcatheter aortic valve implantation.
    Skaar E; Eide LSP; Norekvål TM; Ranhoff AH; Nordrehaug JE; Forman DE; Schoenenberger AW; Hufthammer KO; Kuiper KK; Bleie Ø; Packer EJS; Langørgen J; Haaverstad R; Schaufel MA
    Eur Heart J Qual Care Clin Outcomes; 2019 Apr; 5(2):153-160. PubMed ID: 30256921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of length of stay after transfemoral transcatheter aortic valve implantation with SAPIEN 3 prosthesis: A French multicentre prospective observational trial.
    Durand E; Le Breton H; Lefevre T; Gilard M; Himbert D; Alcazar MU; Bettinger N; Auffret V; Didier R; Chevalier B; Béziau DM; Iung B; Eltchaninoff H
    Arch Cardiovasc Dis; 2020; 113(6-7):391-400. PubMed ID: 32418883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Heart Team" decision making in elderly patients with symptomatic aortic valve stenosis who underwent AVR or TAVI - a look behind the curtain. Results of the prospective TAVI Calculation of Costs Trial (TCCT).
    Kaier K; Gutmann A; Vach W; Sorg S; Siepe M; von Zur Mühlen C; Moser M; Blanke P; Beyersdorf F; Zehender M; Bode C; Reinöhl J
    EuroIntervention; 2015 Nov; 11(7):793-8. PubMed ID: 25499832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter Aortic Valve Implantation (TAVI) Versus Surgical Aortic Valve Replacement for Aortic Stenosis (SAVR): A Cost-Comparison Study.
    Shah KK; Elder D; Nguyen MTH; Turner L; Doyle M; Woldendorp K; Seco M; Law CK; Wilson MK; Keech A; Ng MK; Morton RL
    Heart Lung Circ; 2021 Dec; 30(12):1918-1928. PubMed ID: 34226106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk.
    Kolkailah AA; Doukky R; Pelletier MP; Volgman AS; Kaneko T; Nabhan AF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD013319. PubMed ID: 31860123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher Edmonton Frail Scale prior to transcatheter Aortic Valve Implantation is related to longer hospital stay and mortality.
    Holierook M; Henstra MJ; Dolman DJ; Chekanova EV; Veenis L; Beijk MAM; de Winter RJ; Baan J; Vis MM; Lemkes JS; Snaterse M; Henriques JPS; Delewi R
    Int J Cardiol; 2024 Mar; 399():131637. PubMed ID: 38065322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis.
    Swift SL; Puehler T; Misso K; Lang SH; Forbes C; Kleijnen J; Danner M; Kuhn C; Haneya A; Seoudy H; Cremer J; Frey N; Lutter G; Wolff R; Scheibler F; Wehkamp K; Frank D
    BMJ Open; 2021 Dec; 11(12):e054222. PubMed ID: 34873012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.
    Bouleti C; Chauvet M; Franchineau G; Himbert D; Iung B; Alos B; Brochet E; Urena M; Ghodbane W; Ou P; Provenchere S; Nataf P; Vahanian A
    Eur J Cardiothorac Surg; 2017 Jan; 51(1):80-88. PubMed ID: 27582074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive geriatric assessment in patients undergoing transcatheter aortic valve implantation - results from the CGA-TAVI multicentre registry.
    Ungar A; Mannarino G; van der Velde N; Baan J; Thibodeau MP; Masson JB; Santoro G; van Mourik M; Jansen S; Deutsch C; Bramlage P; Kurucova J; Thoenes M; Maggi S; Schoenenberger AW
    BMC Cardiovasc Disord; 2018 Jan; 18(1):1. PubMed ID: 29301486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.
    Durand E; Beziau-Gasnier D; Michel M; Iung B; Tchetche D; Bonnet G; Lhermusier T; Gilard M; Souteyrand G; Bouleti C; Ohlmann P; Lefevre T; Beygui F; Chassaing S; Chevreul K; Eltchaninoff H; ;
    Eur Heart J; 2024 Mar; 45(11):952-962. PubMed ID: 38437633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.